HDSA Center of Excellence at UC Davis Medical Center is currently recruiting for the PRE CELL observational study (no intervention). A group of up to 40 patients with early-stage Huntington’s Disease (HD) will be enrolled in this observational trial to establish a baseline and study changes over time in measures of movement, thinking, behavior, brain imaging, blood and spinal fluid markers. The information from the study assessments will help Dr. Wheelock and the research team learn more about the rate of change in these measures in people with early-stage HD. Participants enrolled in this study may be eligible to participate in a future planned study of stem cell therapy for Huntington’s Disease. For information regarding eligibility and to be considered for the study, please contact Terry Tempkin, Nurse Practitioner at 916-734-6278 or teresa.tempkin@ucdmc.ucdavis.edu
Share Tweet

Share a link